X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

INTERNATIONAL OPHTHALMOLOGY

期刊標題檢索 INT OPHTHALMOL 最新評論: The article has been accepted (2023-09-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[INTERNATIONAL OPHTHALMOLOGY]您好,您是該頁面的第 20754 位訪客。

期刊簡介
期刊名稱INTERNATIONAL OPHTHALMOLOGY INTERNATIONAL OPHTHALMOLOGY
LetPub Score
5.2
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
7.1

期刊簡稱INT OPHTHALMOL
ISSN0165-5701
E-ISSN1573-2630
h-index40
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.200.7090.826
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Ophthalmology
Q256 / 137

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
International Ophthalmology provides the clinician with articles on all the relevant subspecialties of ophthalmology, with a broad international scope. The emphasis is on presentation of the latest clinical research in the field. In addition, the journal includes regular sections devoted to new developments in technologies, products, and techniques.
官方網站https://www.springer.com/10792
在線稿件提交https://submission.nature.com/new-submission/10792/3
開放訪問No
出版商Springer Netherlands
主題領域OPHTHALMOLOGY
出版國/地區NETHERLANDS
發行頻率年12回刊行
創刊年1978
每年文章數291每年文章數趨勢
黃金OA百分比15.99%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ361/95
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0165-5701%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【INTERNATIONAL OPHTHALMOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640967
    BIOMATERIALS575354
    BIOMEDICINE & PHARMACOTHERAPY498369
    Frontiers in Pharmacology487361
    JOURNAL OF ETHNOPHARMACOLOGY479441
    Journal of Materials Chemistry B476067
    Frontiers in Immunology458033
    COLLOIDS AND SURFACES B-BIOINTERFACES419248
    COMPUTERS IN BIOLOGY AND MEDICINE416602
    Frontiers in Oncology413511
  •  

    INTERNATIONAL OPHTHALMOLOGY INTERNATIONAL OPHTHALMOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [INTERNATIONAL OPHTHALMOLOGY] 的評論撰寫評論
作者: 东京梦森


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-21 23:16:26 評論於
The article has been accepted
(0) 讚! | 东京梦森

作者: 乌苏拉泽凡尼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-30 19:56:47 評論於
It has been three months and there is no progress on my end
(0) 讚! | 乌苏拉泽凡尼

作者: 云居烨赫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-21 18:42:09 評論於
Do you accept dual communications?
(0) 讚! | 云居烨赫

作者: 云居烨赫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-21 11:16:16 評論於
Do you accept dual communication?
(0) 讚! | 云居烨赫

作者: 月河小星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-05 08:41:54 評論於
Submitted in October 2021, currently still in editor assigned
(0) 讚! | 月河小星

作者: 是你的幼白呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-03 15:14:55 評論於
Review speed: 4.0 | Submission hit rate: 75.0
Experience sharing: Submitted on August 26, 2022. Major revision on January 15, 2023. Minor revision on January 26, 2023. Accepted on April 22, 2023
(0) 讚! | 是你的幼白呀

作者: 芙蓉承颜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-27 11:56:00 評論於
Is there a follow-up?
(0) 讚! | 芙蓉承颜

作者: 碧秋超级甜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-27 18:04:19 評論於
Doesn't it not accept dual communication?
(0) 讚! | 碧秋超级甜

作者: 幽花绢子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-08 09:24:39 評論於
Bro, how long has your application been under review? It's been over two months for me and there's been no progress
(0) 讚! | 幽花绢子

作者: 东京梦森


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-01 14:39:35 評論於
The article has been accepted, right?
(0) 讚! | 东京梦森

作者: 东京梦森


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-08 13:47:11 評論於
I have been submitting to this magazine for three months now, and it is currently under review. I'm not sure what the situation is
(0) 讚! | 东京梦森

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:18:23 評論於
Almost all submissions that meet the academic standards for publication undergo revisions by the authors before being accepted for publication. These revisions may involve changes to the wording and formatting, such as condensing the length of the article, redesigning tables, improving the quality of figures, and restricting the use of irregular abbreviations. However, revised manuscripts do not guarantee acceptance; the final decision on acceptance depends on whether the authors have adequately addressed the key content and text modifications requested by the reviewers and editors.

The materials typically provided to authors for revisions include the original manuscript, reviewers' comments, and a cover letter from the editor. Upon receiving the revised manuscript, authors should carefully read the cover letter and reviewers' comments to determine if they are able and willing to implement the suggestions from the reviewers and editor. The likelihood of acceptance can be inferred from the responses of the handling editor and reviewers. It is important not to rush the revision process; authors should carefully consider and address each comment made by the reviewers, indicating specific changes made to the revised manuscript (page numbers, lines) and explaining any sections where modifications were not made
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:08:13 評論於
Submission completed - Format review - Initial editing - Peer review - Review completed - Final editing - Author revision
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 10:30:52 評論於
What is the process of refunds?
(0) 讚! | 修然小公主

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 13:08:55 評論於
What is the process of peer review?
(0) 讚! | 上清雨真

作者: Marlon Louis


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-31 23:06:12 評論於
Hello, how long does it typically take for the first review? And from submission to acceptance, how long does it usually take?
(0) 讚! | Marlon Louis

作者: 岭南乐童


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-03-04 15:36:35 評論於
This magazine has a decent submission speed, good editors, and timely email responses, making it worth recommending to everyone
(0) 讚! | 岭南乐童

作者: 岭南乐童


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-03-03 12:18:30 評論於
This magazine has a good submission speed, and the editors are very good. They respond to emails in a timely manner, and I would recommend it to everyone
(0) 讚! | 岭南乐童

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [INTERNATIONAL OPHTHALMOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*